BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL)

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2006–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	1
2025	—	4	1
2024	—	5	1
2023	—	5	1
2022	—	5	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	6	1
2013	—	4	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	3	1
2008	—	4	1
2007	—	3	1
2006	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
TARPLIN, DOWNS & YOUNG, LLC	—	86

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	83
HOUSE OF REPRESENTATIVES	82
Health & Human Services, Dept of (HHS)	82
Food & Drug Administration (FDA)	72
Centers For Medicare and Medicaid Services (CMS)	49
White House Office	14
Office of Management & Budget (OMB)	9
Natl Institutes of Health (NIH)	4

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	80
Medicare/Medicaid	Medicare/Medicaid	69
Budget/Appropriations	Budget/Appropriations	65
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	10

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 8018119th Congress

ISLET Act

2026 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 4612/H.R. 9000 - the SCREEN For T1D Act S. 8270/H.R. 8018 - the ISLET Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to Special Diabetes Program Issues pertaining to FDA modernization

Client expense: — · Firm income: $40,000

Matched citations: H.R. 8018

H.R. 8646119th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

2026 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Issues pertaining to NIH & FDA funding

Client expense: — · Firm income: $40,000

Matched citations: H.R. 8646

H.R. 9000119th Congress

SCREEN for Type 1 Diabetes Act of 2026

2026 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 4612/H.R. 9000 - the SCREEN For T1D Act S. 8270/H.R. 8018 - the ISLET Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to Special Diabetes Program Issues pertaining to FDA modernization

Client expense: — · Firm income: $40,000

Matched citations: H.R. 9000

H.R. 9620119th Congress

Military Next-Gen Collision Avoidance Act of 2026

2026 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Issues pertaining to NIH & FDA funding

Client expense: — · Firm income: $40,000

Matched citations: H.R. 9620

Show 21 more cited filings

S. 4612119th Congress

SCREEN for Type 1 Diabetes Act of 2026

2026 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 4612/H.R. 9000 - the SCREEN For T1D Act S. 8270/H.R. 8018 - the ISLET Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to Special Diabetes Program Issues pertaining to FDA modernization

Client expense: — · Firm income: $40,000

Matched citations: S. 4612

H.R. 8018119th Congress

ISLET Act

2026 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 4612/H.R. 9000 - the SCREEN For T1D Act S. 8270/H.R. 8018 - the ISLET Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to Special Diabetes Program Issues pertaining to FDA modernization

Client expense: — · Firm income: $80,000

Matched citations: H.R. 8018

H.R. 8646119th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

2026 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Issues pertaining to NIH & FDA funding

Client expense: — · Firm income: $80,000

Matched citations: H.R. 8646

H.R. 9000119th Congress

SCREEN for Type 1 Diabetes Act of 2026

2026 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 4612/H.R. 9000 - the SCREEN For T1D Act S. 8270/H.R. 8018 - the ISLET Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to Special Diabetes Program Issues pertaining to FDA modernization

Client expense: — · Firm income: $80,000

Matched citations: H.R. 9000

H.R. 9620119th Congress

Military Next-Gen Collision Avoidance Act of 2026

2026 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Issues pertaining to NIH & FDA funding

Client expense: — · Firm income: $80,000

Matched citations: H.R. 9620

S. 4612119th Congress

SCREEN for Type 1 Diabetes Act of 2026

2026 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 4612/H.R. 9000 - the SCREEN For T1D Act S. 8270/H.R. 8018 - the ISLET Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to Special Diabetes Program Issues pertaining to FDA modernization

Client expense: — · Firm income: $80,000

Matched citations: S. 4612

H.R. 4121119th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

2026 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026

Client expense: — · Firm income: $80,000

Matched citations: H.R. 4121

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2026 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026

Client expense: — · Firm income: $80,000

Matched citations: H.R. 5304

H.R. 5371119th Congress

Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026

2026 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026

Client expense: — · Firm income: $80,000

Matched citations: H.R. 5371

H.R. 5461119th Congress

Special Diabetes Program Reauthorization Act of 2025

2026 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce

Client expense: — · Firm income: $80,000

Matched citations: H.R. 5461

H.R. 5488119th Congress

Special Diabetes Program for Indians Reauthorization Act of 2025

2026 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce

Client expense: — · Firm income: $80,000

Matched citations: H.R. 5488

S. 2211119th Congress

Special Diabetes Program Reauthorization Act of 2025

2026 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce

Client expense: — · Firm income: $80,000

Matched citations: S. 2211

S. 2256119th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

2026 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026

Client expense: — · Firm income: $80,000

Matched citations: S. 2256

S. 2587119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2026 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026

Client expense: — · Firm income: $80,000

Matched citations: S. 2587

H.R. 4121119th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

2025 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026

Client expense: — · Firm income: $80,000

Matched citations: H.R. 4121

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026

Client expense: — · Firm income: $80,000

Matched citations: H.R. 5304

H.R. 5371119th Congress

Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026

2025 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026

Client expense: — · Firm income: $80,000

Matched citations: H.R. 5371

H.R. 5461119th Congress

Special Diabetes Program Reauthorization Act of 2025

2025 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce

Client expense: — · Firm income: $80,000

Matched citations: H.R. 5461

H.R. 5488119th Congress

Special Diabetes Program for Indians Reauthorization Act of 2025

2025 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce

Client expense: — · Firm income: $80,000

Matched citations: H.R. 5488

S. 2211119th Congress

Special Diabetes Program Reauthorization Act of 2025

2025 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce

Client expense: — · Firm income: $80,000

Matched citations: S. 2211

S. 2256119th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

2025 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026

Client expense: — · Firm income: $80,000

Matched citations: S. 2256

Source: Senate LDA

BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) — Lobbying Disclosure | Poliscope